| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 2,223.8 | 3,056.2 | 2,775.8 | 696.99 |
Depreciation | -814.3 | -835 | -789.2 | -774.1 |
Tax paid | -600.6 | -869.8 | 161.9 | -130.1 |
Working capital | 1,395.8 | 1,078.3 | 508.8 | -170.1 |
Other operating items | ||||
Operating | 2,204.7 | 2,429.7 | 2,657.3 | -377.3 |
Capital expenditure | 1,004.1 | 2,129.1 | 992.29 | 548.2 |
Free cash flow | 3,208.8 | 4,558.8 | 3,649.6 | 170.9 |
Equity raised | 33,530.3 | 29,823 | 23,896 | 23,007.52 |
Investing | 287.5 | -836.3 | 1,849 | 534.6 |
Financing | 3,419.9 | 2,632.8 | 4,045.7 | 4,944 |
Dividends paid | 0 | 0 | 0 | 331.82 |
Net in cash | 40,446.5 | 36,178.3 | 33,440.3 | 28,988.84 |
Senores Pharmaceuticals intends to fund the acquisition through proceeds from its IPO, which raised ₹5.82 billion in December.
Here are some of the stocks that may see significant price movement today: KPI Green, Tata Power, UltraTech Cement, etc.
Dr Reddy's Laboratories third quarter net profit rose 2.5% year-on-year (YoY) to ₹1,413.3 crore.
The company logged a growth of 15.9% in its revenue from operations at ₹8,358.60 Crore versus ₹7,215 Crore in Q3FY24.
Here are some of the stocks that may see significant price movement today: Indus Towers, Dr Reddy’s Laboratories, Mankind Pharma, etc.
Here are some of the stocks that may see significant price movement today: Dr Reddy’s Laboratories, RITES, Canara Bank, etc.
Dr Reddy's already signed a license and commercialisation deal for Toripalimab with Shanghai Junshi Biosciences Co. Ltd in 2023.
Dr Reddy’s Laboratories shares has gained a total of 5.62% in the last one year, and 2.45% since the beginning of the year.
Here are some of the stocks that may see significant price movement today: UPL, Tata Power, JSW Steel, Dr Reddy’s, etc.
EBITDA for the quarter increased 5% year-on-year to ₹2,280 Crore between July and September 2024, while margins improved modestly to 28.4%.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
